iBET - Instituto de Biologia Experimental e Tecnologica

iBET is a private non-profit research institution specialized in biotechnology research and bioprocess development. iBET acts as an interface between academia and industry while also creating and organizing autonomous knowledge. Our expertise includes the development of bioprocesses for complex biopharmaceuticals and advanced therapies, including vaccines, recombinant proteins, and viral vectors for gene and onco- therapy, stem cells for cell therapy applications; development of in-vitro cell models and protocols for pre-clinical research; analytical tools for quality control of biologics; and structural biology for assisted drug design. Within Food and Health, we develop new solutions for the detection of food frauds, food...

Proteins,bioprocess development,pre-clinical models,cell lines,pilot plant,analytical services,nutraceuticals,cell based assays,viral vectors,stem cells,clinical,atmps,gene therapy,cdmo,bioactives,bioplastics,new materials,virus,cell therapy,bioengineering,production,manufacturing,vaccines,gene therapy,and biopharmaceuticals

Ibet - instituto de biologia experimental e tecnologica operates in the Biotechnology research industry.

Ibet - instituto de biologia experimental e tecnologica's revenue is 11m - 100m

Ibet - instituto de biologia experimental e tecnologica has 201 - 500 employees.